INFLARX NV's ticker is IFRX and the CUSIP is N44821101. A total of 28 filers reported holding INFLARX NV in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,087,052 | -33.2% | 5,733,910 | 0.0% | 0.92% | -32.5% |
| Q2 2023 | $25,573,239 | +514.2% | 5,733,910 | +167.2% | 1.37% | +676.7% |
| Q1 2023 | $4,163,706 | -37.4% | 2,146,240 | 0.0% | 0.18% | -36.9% |
| Q4 2022 | $6,653,344 | +17.4% | 2,146,240 | 0.0% | 0.28% | +18.7% |
| Q3 2022 | $5,666,000 | +19.0% | 2,146,240 | -34.7% | 0.24% | +29.8% |
| Q2 2022 | $4,763,000 | -20.8% | 3,285,000 | 0.0% | 0.18% | -1.6% |
| Q1 2022 | $6,012,000 | -61.6% | 3,285,000 | 0.0% | 0.18% | -39.3% |
| Q4 2021 | $15,637,000 | +83.8% | 3,285,000 | 0.0% | 0.30% | +111.9% |
| Q3 2021 | $8,508,000 | -12.8% | 3,285,000 | 0.0% | 0.14% | -2.1% |
| Q2 2021 | $9,756,000 | -23.9% | 3,285,000 | 0.0% | 0.15% | -22.8% |
| Q1 2021 | $12,812,000 | – | 3,285,000 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 1,876,413 | $54,116,000 | 31.91% |
| RA Capital Management | 1,620,653 | $46,740,000 | 3.58% |
| Cormorant Asset Management, LP | 1,399,030 | $40,348,000 | 3.01% |
| EMORY UNIVERSITY | 90,761 | $2,618,000 | 1.87% |
| Redmile Group, LLC | 851,100 | $24,546,000 | 0.95% |
| Eventide Asset Management | 275,000 | $7,931,000 | 0.37% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,394,132 | $40,207,000 | 0.09% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 88,500 | $2,552,000 | 0.09% |
| Baker Brothers Advisors | 200,000 | $5,768,000 | 0.05% |
| Artal Group S.A. | 125,000 | $3,605,000 | 0.04% |